Vijay Chavan

Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis

Lorenzo Guglielmetti, Uzma Khan, Gustavo E. Velásquez et al. · New England Journal of Medicine · 2025 · 54 citations · Full text

Clinical utility of target-based next-generation sequencing for drug-resistant TB

Homa Mansoor, Nilma Hirani, Vijay Chavan et al. · The International Journal of Tuberculosis and Lung Disease · 2023 · 37 citations · Full text

Treatment outcomes of children and adolescents receiving drug-resistant TB treatment in a routine TB programme, Mumbai, India

Shubhangi Dhakulkar, Mrinalini Das, Narendra Sutar et al. · PLoS ONE · 2021 · 22 citations · Full text

Ambulatory management of pre- and extensively drug resistant tuberculosis patients with imipenem delivered through port-a-cath: A mixed methods study on treatment outcomes and challenges

Vijay Chavan, Alpa Dalal, Sharath Burugina Nagaraja et al. · PLoS ONE · 2020 · 16 citations · Full text

Nine-month, all-oral regimens for rifampin-resistant tuberculosis

Lorenzo Guglielmetti, Uzma Khan, Gustavo E. Velásquez et al. · 2024 · 12 citations · Full text

Poor Treatments, Pulmonary Tuberculosis, Health Sciences +13